Disulfide-crosslinked nanomicelles confer cancer-specific drug delivery and improve efficacy of paclitaxel in bladder cancer-Reference-Cited by-同舟云学术

Disulfide-crosslinked nanomicelles confer cancer-specific drug delivery and improve efficacy of paclitaxel in bladder cancer

Published:2016-09-19 Issue:42 Volume:27 Page:425103
ISSN:0957-4484
Container-title:Nanotechnology
language:
Short-container-title:Nanotechnology

Author:

Pan Amy,Zhang Hongyong,Li Yuanpei,Lin Tzu-yin,Wang Fuli,Lee Joyce,Cheng Mingshan,Dall’Era Marc,Li Tianhong,deVere White Ralph,Pan Chong-Xian,Lam Kit S

Funder

VA Merit

National Cancer Institute

Publisher

IOP Publishing

Subject

Electrical and Electronic Engineering,Mechanical Engineering,Mechanics of Materials,General Materials Science,General Chemistry,Bioengineering

Link

http://stacks.iop.org/0957-4484/27/i=42/a=425103/pdf

Reference19 articles.

1. Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes

2. Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer

3. A novel size-tunable nanocarrier system for targeted anticancer drug delivery

4. Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical insights into nanomedicine and biosafety: advanced therapeutic approaches for common urological cancers;Frontiers in Oncology;2024-08-13

2. Current advances in the application of nanomedicine in bladder cancer;Biomedicine & Pharmacotherapy;2023-01

3. The Application of Nanomedicine in the Intravesical Instillation Therapy of Non-muscle Invasive Bladder Cancer;ACTA POLYM SIN;2023

4. Nanomedicines for Therapy of Bladder Cancer;The Korean Journal of Urological Oncology;2022-11-30

5. State-of-the-Art Advances of Nanomedicine for Diagnosis and Treatment of Bladder Cancer;Biosensors;2022-09-27